Inherited Collagen Defect in the Connective Tissue of Dogs (Ehlers-Danlos Syndrome, Cutaneous Asthenia)
- Occurrence: very rare
- Location of disease: Skin/Fur
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Das Wichtigste auf einen Blick
Ehlers-Danlos syndrome (EDS) in dogs is a genetic disorder caused by defects in collagen synthesis. Collagen is crucial for the strength and elasticity of the skin and other tissues. In dogs with EDS, the collagen is abnormal, leading to a weakening of the connective tissue. Inheritance is usually autosomal recessive, meaning that both parents must be carriers of the defective gene. However, some breeds may also exhibit autosomal dominant inheritance. Affected dog breeds include Irish Setters, Boxers, Beagles, and Poodles. Symptoms include loose skin, skin wrinkling, easy injury to the skin, and loose joints. Diagnosis is made through clinical examinations, skin biopsies, and genetic tests. There is no cure, so treatment focuses on managing symptoms and avoiding injuries. Wounds must be carefully treated to prevent infections. Preventive measures include breeding controls and avoiding injury risks. Research focuses on genetic causes, diagnostic tests, and potential treatments. The prognosis varies depending on the severity of the disorder, with quality of life being significantly impaired in more severe forms. An interdisciplinary research approach aims to lead to better diagnostic and treatment options in the future.
Ursachen
Ehlers-Danlos syndrome in dogs is a genetic disorder caused by defects in collagen synthesis. Collagen is an important structural protein that ensures the strength and elasticity of the skin and other tissues. In dogs with this disorder, the collagen is abnormally structured, leading to a weakness of the connective tissue.
The genetic basis of the condition can vary, but often an autosomal recessive inheritance pattern is responsible. This means that both parents must be carriers of the defective gene for a puppy to be affected. In some breeds, it can also be inherited in an autosomal dominant manner, meaning that only one parent needs to pass on the defective gene.
There are different types of Ehlers-Danlos syndrome, caused by various genetic mutations. Affected breeds include Irish Setters, Boxers, Beagles, and Poodles, among others. Each breed can show different clinical manifestations, depending on the type of collagen deficiency.
Symptoms
The symptoms of cutaneous asthenia in dogs are primarily limited to the skin. Affected dogs show unusually stretchable and fragile skin that can be easily injured. The skin tends to split on its own or tear with minor trauma, leading to bleeding wounds.
Additional symptoms can include scar tissue formation, skin infections due to increased susceptibility to wounds, and hematomas (bruises). In some dogs, joint problems may also occur, as collagen plays a role there as well.
In more severe cases, internal organs may also be affected. However, this is rare and tends to occur in advanced stages of the disease. The symptoms can vary in intensity, depending on the severity of the genetic mutation and the affected breed.
Diagnose
The diagnosis of Hyperostosis cutis, or Ehlers-Danlos syndrome, is usually made through a combination of clinical examination and specific tests. The veterinarian will check skin elasticity and strength by lifting the skin and examining how far it stretches and how quickly it returns to its original shape.
A biopsy of the skin can also be performed to examine the structure of the collagen under the microscope. This examination can provide information on whether the collagen is abnormal. In some cases, genetic tests can be performed to identify the specific mutation, especially in breeds that are predisposed to the disorder.
Additionally, blood tests can be performed to rule out other possible causes of skin problems. It is important to establish an accurate diagnosis in order to develop an appropriate treatment strategy.
Therapie
There is currently no cure for Ehlers-Danlos syndrome in dogs, so treatment focuses on managing symptoms and preventing injuries. Affected dogs should be kept in a safe environment to minimize the risk of skin injuries.
Wounds must be carefully monitored and treated to prevent infections. This may include the application of antiseptic solutions and, if necessary, antibiotics. In severe injuries, surgical intervention may be required, although healing can be delayed due to the collagen problem.
Pain relief and anti-inflammatory medications may be necessary to alleviate discomfort. In some cases, dietary supplementation with vitamin C may be considered, as it plays a role in collagen synthesis, although the effectiveness of this treatment is controversial.
Prognose und Nachsorge
The prognosis for dogs with Hyperostosis cutis varies depending on the severity of the disorder. Dogs with mild forms of the disorder can lead a relatively normal life with appropriate management. In more severe forms, however, quality of life can be significantly impaired, as continuous care and protection are required.
A worsening of symptoms can occur over time, especially if injuries are not carefully avoided. Life expectancy may decrease, particularly if internal organs are affected or severe infections occur.
Prävention
Since Ehlers-Danlos syndrome is genetic, prevention focuses primarily on breeding control. Breeders should take care not to breed affected dogs or carriers of the defective gene. Genetic tests can help identify carriers and should be considered in breeds with a known predisposition.
For affected dogs, it is important to create an environment that minimizes the risk of injury. This may include avoiding sharp or rough surfaces and wearing protective clothing to protect the skin. Regular veterinary monitoring is also important to assess the dog’s health status and detect complications early.
Ausblick auf aktuelle Forschung
Current research on Ehlers-Danlos syndrome (EDS) in dogs, particularly cutaneous asthenia, focuses on the genetic basis of the disorder. Scientists are investigating specific genetic mutations responsible for abnormal collagen production. These mutations lead to reduced strength and elasticity of the skin, contributing to the typical symptoms of the disorder. Researchers use modern genetic sequencing technologies to identify and better understand the responsible genes.
Another area of research is the development of diagnostic tests that enable early and precise diagnosis. This is crucial to provide affected dogs with the right care in a timely manner. Researchers are working on developing non-invasive tests based on the analysis of skin samples or blood to detect genetic markers for EDS.
Therapeutic approaches are also a research focus. Currently, there is no cure for EDS, but researchers are investigating various treatment options to improve the quality of life of affected dogs. These include the development of medications that could influence collagen production, as well as physiotherapeutic measures to support the affected animals.
In addition to genetic and therapeutic research, scientists are working to deepen the understanding of the clinical manifestations of the disease. This includes examining the different degrees of severity and symptoms that can occur in affected dogs. A better understanding of this variability can help veterinarians develop individually tailored treatment plans.
An interdisciplinary approach is crucial for progress in EDS research. Veterinarians, geneticists, and biologists work together to investigate the various aspects of the disease and develop effective solutions. This collaborative approach promises to enable groundbreaking discoveries in the future that could significantly improve the understanding and treatment of EDS in dogs.
Frequently Asked Questions (FAQs)
1. What is Ehlers-Danlos syndrome (EDS) in dogs?
2. Which dogs are affected by EDS?
3. What symptoms occur in dogs with EDS?
4. How is EDS diagnosed in dogs?
5. Is there a cure for EDS in dogs?
6. Can dogs with EDS lead a normal life?
7. How can I help my dog with EDS?
8. Is EDS in dogs contagious?
9. What progress is being made in EDS research?
10. Can EDS in dogs be prevented?
Literatur
- Bullock, G., Jaffey, J. A., Cohn, L. A., Sox, E., Hostnik, E. T., Hutcheson, K. D., Matero, E., Hoffmann, K. S., Johnson, G. S., & Katz, M. L. (2024). Novel COL5A1 variants and associated disease phenotypes in dogs with classical Ehlers–Danlos syndrome. Journal of Veterinary Internal Medicine, 38(5), 2431–2443. https://doi.org/10.1111/jvim.17180
- Bauer, A., Bateman, J. F., Lamandé, S. R., Hanssen, E., Kirejczyk, S. G. M., Yee, M., Ramiche, A., Jagannathan, V., Welle, M., Leeb, T., & Bateman, F. L. (2019). Identification of two independent COL5A1 variants in dogs with Ehlers–Danlos syndrome. Genes, 10(10), 731. https://doi.org/10.3390/genes10100731
- Kiener, S., Chevallier, L., Jagannathan, V., Briand, A., Cochet-Faivre, N., Reyes-Gomez, E., & Leeb, T. (2022). A COL5A2 in-frame deletion in a Chihuahua with Ehlers–Danlos syndrome. Genes, 13(5), 934. https://doi.org/10.3390/genes13050934
- Jaffey, J. A., Bullock, G., Guo, J., Mhlanga-Mutangadura, T., O’Brien, D. P., Coates, J. R., Morrissey, R., Hutchison, R., Donnelly, K. S., Cohn, L. A., Katz, M. L., & Johnson, G. S. (2022). Novel homozygous ADAMTS2 variants and associated disease phenotypes in dogs with dermatosparactic Ehlers–Danlos syndrome. Genes, 13(11), 2158. https://doi.org/10.3390/genes13112158
- Paciello, O., Lamagna, F., Lamagna, B., & Papparella, S. (2003). Ehlers-Danlos-like syndrome in 2 dogs: Clinical, histologic, and ultrastructural findings. Veterinary Clinical Pathology, 32(1), 13–18. https://doi.org/10.1111/j.1939-165X.2003.tb00306.x
- Bellini, M. H., Schor, N., & Soares, A. M. V. C. (2009). Increased elastic microfibrils and thickening of fibroblastic nuclear lamina in canine cutaneous asthenia. Veterinary Dermatology, 20(2), 139–143. https://doi.org/10.1111/j.1365-3164.2008.00732.x
- Poulsen, P. H., Flagstad, A., & Basse, A. (1985). Cutaneous asthenia in the dog: A report of two cases. Acta Veterinaria Scandinavica, 26(3), 467–475.
- Rasch, S. N., Long, A. J., & Conway, J. A. (2017). Surgical and medical treatment of ocular disease in a dog with Ehlers–Danlos syndrome. Clinical Case Reports, 5(7), 1198–1203. https://doi.org/10.1002/ccr3.972